CH
SGYP

CVI Holdings’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CVI Holdings’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,767,858
Closed -$3.23M – 69
2018
Q1 		$3.23M Buy
+1,767,858
New +$3.73M 4.39% 6

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CVI Holdings's SGYP Position: Q2 2018 in Review

CVI Holdings sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 1,767,858 shares — an estimated $3.23M sold.

CVI Holdings first reported a position in SGYP in Q1 2018 and held it in 1 quarter. The position peaked at $3.23M in Q1 2018. 137 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

  • CVI Holdings reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
  • CVI Holdings sold 1,767,858 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $3.23M.
  • CVI Holdings first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2018 and held it in 1 quarter.
  • CVI Holdings's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3.23M in Q1 2018.
  • 137 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.